Oculis Holding AG (OCS) Times Interest Earned (2022 - 2026)
Oculis Holding AG (OCS) recorded quarterly Times Interest Earned of -$1.21 in Q1 2026, up 29.16% quarter-over-quarter from -$1.71 in Q4 2025, and down 4.7% on a YoY basis from -$1.27 in Q1 2025.
Oculis Holding AG (OCS) Times Interest Earned (2022 - 2026) Analysis & Trends
Oculis Holding AG's Times Interest Earned history runs 5 years deep, the most recent figure standing at -$1.21 for Q1 2026.
- In Q1 2026, Times Interest Earned fell 4.7% year-over-year to -$1.21; the TTM figure through Mar 2026 stood at -$0.01 (up 99.95% YoY), while the FY2025 annual figure was -$1.44, down 34.08% from the prior year.
- Times Interest Earned was -$1.21 for Q1 2026 at Oculis Holding AG, up from -$1.71 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of -$0.0 in Q3 2024 to a low of -$12145.7 in Q4 2024.
- Historically, Times Interest Earned has averaged -$763.13 across 5 years, with a median of -$1.32 in 2025.
- Biggest YoY gain for Times Interest Earned was 100.0% in 2024; the steepest drop was 78683.24% in 2024.
- A 5-year view of Times Interest Earned shows it stood at -$0.16 in 2022, then slumped by 9430.96% to -$15.42 in 2023, then plunged by 78683.24% to -$12145.7 in 2024, then jumped by 99.99% to -$1.71 in 2025, then gained by 29.16% to -$1.21 in 2026.
- The last three Times Interest Earned figures came in at -$1.21 (Q1 2026), -$1.71 (Q4 2025), and -$0.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 3.58 |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | -258.33 |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | 11.50 |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | - |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | 11.79 |
| 10 | Oculis Holding AG | 8.23 Bn | 7.92 Bn | - | -1.21 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.21 |
| Dec 31, 2025 | -1.71 |
| Sep 30, 2025 | 0.00 |
| Jun 30, 2025 | -1.43 |
| Mar 31, 2025 | -1.15 |
| Dec 31, 2024 | -12,145.75 |
| Sep 30, 2024 | 0.00 |
| Jun 30, 2024 | -2.82 |
| Mar 31, 2024 | -5.41 |
| Dec 31, 2023 | -15.42 |
| Sep 30, 2023 | -19.91 |
| Jun 30, 2023 | -14.71 |
| Mar 31, 2023 | -0.18 |
| Dec 31, 2022 | -0.16 |
| Sep 30, 2022 | -0.11 |
| Jun 30, 2022 | -0.14 |